Lymphodepleting Chemotherapy
1 clinical trials · Condition
◉ Watch Lymphodepleting Chemotherapy
| Record | Firm | Date |
|---|---|---|
| Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies (NCT06383572) | M.D. Anderson Cancer Center | 2024-06-26 |
Track Lymphodepleting Chemotherapy automatically
Every clearance here is in the API, with alerts when new ones post.